The Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines has authorised the second clinical study with COVID-19 reconvalescent plasma (RECOVER) in Germany. The purpose of such […]
If you have fully recovered from COVID-19, you may be able to help patients currently fighting the infection by donating your plasma. Because you fought […]
The Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, has granted approval for the first clinical trial with COVID-19 convalescent plasma (CAPSID) in Germany. The aim […]
Plasma transfusion is a potentially promising therapy for COVID-19 patients that can be made widely available at relatively short notice by blood services across the […]
Copyright © 2021 | WordPress Theme by MH Themes
